TFS Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-3,852
| Closed | -$257K | – | 1087 |
|
|
2016
Q1 | $257K | Buy |
+3,852
| New | +$257K | 0.04% | 693 |
|
|
2015
Q1 | – | Sell |
-20,727
| Closed | -$688K | – | 1042 |
|
|
2014
Q4 | $688K | Buy |
+20,727
| New | +$688K | 0.07% | 483 |
|
|
2014
Q2 | – | Sell |
-87,163
| Closed | -$3.66M | – | 1247 |
|
|
2014
Q1 | $3.66M | Buy |
+87,163
| New | +$3.66M | 0.24% | 103 |
|
|
2013
Q4 | – | Sell |
-80,249
| Closed | -$2.17M | – | 1552 |
|
|
2013
Q3 | $2.17M | Buy |
80,249
+41,290
| +106% | +$1.11M | 0.1% | 298 |
|
|
2013
Q2 | $909K | Buy |
+38,959
| New | +$909K | 0.04% | 637 |
|